A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004) | MicrobiomeTrials← Back to trialsNCT07895524
A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-11-23Est. Completion: 2027-10-19
Enrollment target: 60 participants Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Rheumatic DiseasesLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemArthritisSpondylarthritisAnkylosing SpondylarthritisRheumatoid ArthritisSjogren's Syndrome
Background:
Rheumatic diseases can affect the joints, ligaments, tendons, bones, muscles, and skin. They can also cause…
Bethesda, United States
Est. completion Jun 15, 2033
Rheumatoid Arthritis
Personalized medicine in which each patient would receive the ideal personalized treatment and regimen, holds great prom…
Montpellier, FranceCompleted Sep 16, 2026